Biodexa Pharmaceuticals Plc
BDRX
Price:
$5.09
Market Cap:
$2.36M
Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes. The company is also developing MTX110, which is currently in Phase I studies for the treatment of diffuse intrinsic recurrent glioblastoma, diffuse midline glioma, and medulloblastoma. In addition, the company offers drug delivery platforms, such as Q-Sphera, a polymer microsp...[Read more]
Industry
Biotechnology
IPO Date
2015-12-07
Stock Exchange
NASDAQ
Ticker
BDRX
PE Ratio
[-0.19]
ROE
[-63.03%]
Current Ratio
[3.63]
Dividend Yield
[0%]
Enterprise Value
[-1174983.86]
Dividend History
The ROE as of December 2025 (TTM) for Biodexa Pharmaceuticals Plc (BDRX) is -63.03%
According to Biodexa Pharmaceuticals Plc’s latest financial reports and current stock price. The company's current ROE is -63.03%. This represents a change of 43.80% compared to the average of -43.83% of the last 4 quarters.
Biodexa Pharmaceuticals Plc (BDRX) Historical ROE (quarterly & annually)
How has BDRX ROE performed in the past?
The mean historical ROE of Biodexa Pharmaceuticals Plc over the last ten years is -102.64%. The current -63.03% ROE has changed -38.59% with respect to the historical average. Over the past ten years (40 quarters), BDRX's ROE was at its highest in in the June 2014 quarter at 490.88%. The ROE was at its lowest in in the June 2020 quarter at -383.11%.
Average
-102.64%
Median
-56.75%
Minimum
-330.29%
Maximum
-13.47%
Biodexa Pharmaceuticals Plc (BDRX) ROE by Quarter and Year
Discovering the peaks and valleys of Biodexa Pharmaceuticals Plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 540.54%
Maximum Annual ROE = -13.47%
Minimum Annual Increase = -84.18%
Minimum Annual ROE = -330.29%
| Year | ROE | Change |
|---|---|---|
| 2024 | -68.84% | -54.51% |
| 2023 | -151.33% | -37.50% |
| 2022 | -242.13% | 363.52% |
| 2021 | -52.24% | -84.18% |
| 2020 | -330.29% | 540.54% |
| 2019 | -51.56% | -15.83% |
| 2018 | -61.26% | 81.49% |
| 2017 | -33.76% | 150.52% |
| 2016 | -13.47% | -37.44% |
| 2015 | -21.54% | 2.52% |
Biodexa Pharmaceuticals Plc (BDRX) Average ROE
How has BDRX ROE performed in the past?
The current ROE of Biodexa Pharmaceuticals Plc (BDRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-154.10%
5-year avg
-168.96%
10-year avg
-102.64%
Biodexa Pharmaceuticals Plc (BDRX) ROE vs. Peers
How is BDRX’s ROE compared to its peers?
Biodexa Pharmaceuticals Plc’s ROE is greater than InMed Pharmaceuticals Inc. (-93.20%), greater than Genprex, Inc. (-877.16%), greater than GRI Bio, Inc. (-327.62%), greater than Jaguar Health, Inc. (-674.39%), less than Estrella Immunopharma, Inc. (686.58%), greater than Galmed Pharmaceuticals Ltd. (-48.35%), greater than CNS Pharmaceuticals, Inc. (-130.12%), greater than BioVie Inc. (-82.81%), less than Kazia Therapeutics Limited (335.37%), greater than Can-Fite BioPharma Ltd. (-182.93%),
| Company | ROE | Market cap |
|---|---|---|
| -93.20% | $2.43M | |
| -877.16% | $5.47M | |
| -327.62% | $5.38M | |
| -674.39% | $2.39M | |
| 686.58% | $72.89M | |
| -48.35% | $6.19M | |
| -130.12% | $3.74M | |
| -82.81% | $12.13M | |
| 335.37% | $21.67M | |
| -182.93% | $3.65M |
Build a custom stock screener for Biodexa Pharmaceuticals Plc (BDRX) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biodexa Pharmaceuticals Plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Biodexa Pharmaceuticals Plc (BDRX) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Biodexa Pharmaceuticals Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Biodexa Pharmaceuticals Plc's ROE?
How is the ROE calculated for Biodexa Pharmaceuticals Plc (BDRX)?
What is the highest ROE for Biodexa Pharmaceuticals Plc (BDRX)?
What is the 3-year average ROE for Biodexa Pharmaceuticals Plc (BDRX)?
What is the 5-year average ROE for Biodexa Pharmaceuticals Plc (BDRX)?
How does the current ROE for Biodexa Pharmaceuticals Plc (BDRX) compare to its historical average?